Recommendations on the use of COVID-19 Convalescent Plasma to Treat Immunocompromised Patients

被引:4
作者
Franchini, Massimo [1 ,6 ]
Casadevall, Arturo [2 ]
Senefeld, Jonathon W. [3 ]
Joyner, Michael J. [4 ]
Sullivan, David J. [2 ]
Focosi, Daniele [5 ]
机构
[1] Carlo Poma Hosp, Dept Transfus Med & Hematol, Mantua, Italy
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA
[3] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA
[4] Mayo Clin, Dept Anesthesiol & Perioperat Med, Rochester, MN USA
[5] Pisa Univ Hosp, North Western Tuscany Blood Bank, Pisa, Italy
[6] Carlo Poma Hosp, Dept Hematol & Transfus Med, Mantua, Italy
关键词
D O I
10.1055/s-0043-1776876
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:648 / 653
页数:6
相关论文
共 11 条
[1]   SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern [J].
Casadevall, Arturo ;
Focosi, Daniele .
JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (06)
[2]   The convalescent sera option for containing COVID-19 [J].
Casadevall, Arturo ;
Pirofski, Liise-Anne .
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (04) :1545-1548
[3]   Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial [J].
Denkinger, Claudia M. ;
Janssen, Maike ;
Schaekel, Ulrike ;
Gall, Julia ;
Leo, Albrecht ;
Stelmach, Patrick ;
Weber, Stefan F. ;
Krisam, Johannes ;
Baumann, Lukas ;
Stermann, Jacek ;
Merle, Uta ;
Weigand, Markus A. ;
Nusshag, Christian ;
Bullinger, Lars ;
Schrezenmeier, Jens-Florian ;
Bornhaeuser, Martin ;
Alakel, Nael ;
Witzke, Oliver ;
Wolf, Timo ;
Vehreschild, Maria J. G. T. ;
Schmiedel, Stefan ;
Addo, Marylyn M. ;
Herth, Felix ;
Kreuter, Michael ;
Tepasse, Phil-Robin ;
Hertenstein, Bernd ;
Haenel, Mathias ;
Morgner, Anke ;
Kiehl, Michael ;
Hopfer, Olaf ;
Wattad, Mohammad-Amen ;
Schimanski, Carl C. ;
Celik, Cihan ;
Pohle, Thorsten ;
Ruhe, Matthias ;
Kern, Winfried, V ;
Schmitt, Anita ;
Lorenz, Hanns-Martin ;
Souto-Carneiro, Margarida ;
Gaeddert, Mary ;
Halama, Niels ;
Meuer, Stefan ;
Kraeusslich, Hans-Georg ;
Mueller, Barbara ;
Schnitzler, Paul ;
Parthe, Sylvia ;
Bartenschlager, Ralf ;
Gronkowski, Martina ;
Klemmer, Jennifer ;
Schmitt, Michael .
NATURE CANCER, 2023, 4 (01) :96-+
[4]   COVID-19 convalescent plasma retains value for immunocompromised patients [J].
Focosi, Daniele ;
Franchini, Massimo .
LEUKEMIA, 2023, 37 (08) :1762-1763
[5]   COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes [J].
Focosi, Daniele ;
Franchini, Massimo ;
Pirofski, Liise-Anne ;
Burnouf, Thierry ;
Paneth, Nigel ;
Joyner, Michael J. ;
Casadevall, Arturo .
CLINICAL MICROBIOLOGY REVIEWS, 2022, 35 (03)
[6]  
Franchini M., SAFETY COVID 19 CONV
[7]   WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients? [J].
Franchini, Massimo ;
Casadevall, Arturo ;
Joyner, Michael J. J. ;
Focosi, Daniele .
LIFE-BASEL, 2023, 13 (01)
[8]  
Senefeld Jonathon W, 2023, Mayo Clin Proc Innov Qual Outcomes, V7, P499, DOI [10.1016/j.mayocpiqo.2023.09.001, 10.1016/j.mayocpiqo.2023.09.001]
[9]   COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis [J].
Senefeld, Jonathon W. ;
Franchini, Massimo ;
Mengoli, Carlo ;
Cruciani, Mario ;
Zani, Matteo ;
Gorman, Ellen K. ;
Focosi, Daniele ;
Casadevall, Arturo ;
Joyner, Michael J. .
JAMA NETWORK OPEN, 2023, 6 (01) :E2250647
[10]  
Sullivan D J., 2022, PREPRINT